ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,309.52
-0.10%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,344.33
-0.32%
Brent Oil
83.035
0.23%
Bitcoin
68,419.90
-1.40%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. NeuBase Therapeutics Inc (NBSE)

  7. NeuBase Therapeutics Inc (NBSE) News

NeuBase Therapeutics (NBSE)

NeuBase Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:NBSE
DateTimeSourceHeadlineSymbolCompany
22/05/202421:59Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
16/05/202415:07Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:NBSENeuBase Therapeutics Inc
13/05/202421:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
06/05/202412:30Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NBSENeuBase Therapeutics Inc
05/04/202421:05GlobeNewswire Inc.NeuBase Therapeutics Announces Receipt of Notice from NasdaqNASDAQ:NBSENeuBase Therapeutics Inc
07/03/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
23/02/202421:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
26/01/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
17/01/202411:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
28/12/202312:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
28/12/202311:15Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:NBSENeuBase Therapeutics Inc
22/12/202311:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
27/11/202314:00GlobeNewswire Inc.Psychemedics Corporation Appoints Daniella Mehalik as VP - FinanceNASDAQ:NBSENeuBase Therapeutics Inc
09/11/202321:11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:NBSENeuBase Therapeutics Inc
06/11/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
06/11/202322:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
20/10/202312:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
18/10/202313:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
29/09/202321:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
21/09/202301:42Edgar (US Regulatory)Form 5 - Annual statement of changes in beneficial ownership of securitiesNASDAQ:NBSENeuBase Therapeutics Inc
20/09/202322:28Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NBSENeuBase Therapeutics Inc
18/09/202321:32Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NBSENeuBase Therapeutics Inc
18/09/202321:20Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:NBSENeuBase Therapeutics Inc
18/09/202321:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:NBSENeuBase Therapeutics Inc
14/09/202311:03Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:NBSENeuBase Therapeutics Inc
12/09/202322:20Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:NBSENeuBase Therapeutics Inc
11/09/202322:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NBSENeuBase Therapeutics Inc
08/09/202312:00GlobeNewswire Inc.NeuBase Therapeutics Issues Statement Regarding Filing By ShareholderNASDAQ:NBSENeuBase Therapeutics Inc
07/09/202322:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:NBSENeuBase Therapeutics Inc
06/09/202315:00PR Newswire (US)SYMETRYX CORPORATION ACQUIRES 20% STOCK IN NEUBASENASDAQ:NBSENeuBase Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:NBSE

Your Recent History

LSE
OEC1
NYSE
RCA
Ready Capital
EU
IAADA
21SHARE AADA INAV
LSE
ENVS
Enova Systems
TIDE
TDXETH
BIT
UI830C
Unicredit Bank
USOTC
CEURF
Century Global Commodities (PK)
EU
NL0000003515
Nlrent0 15jan29
NASDAQ
PBNC
Paragon Commercial Corp.
NYSE
FAM
First Trust abrdn Global...
COIN
WAGIEBOTUSD
WagieBot
TSXV
ORE
Orezone Gold
COIN
HACHIUSD
Hachiko Inu
USOTC
NTDOF
Nintendo (PK)
USOTC
AVSR
Avistar Communications (CE)
TSXV
GMN
Gobimin
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved